Pancreatic cancer gene study aims to personalize care
NCT ID NCT02869802
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study looks at genetic changes in metastatic pancreatic cancer to see if they can help guide treatment choices. Researchers will take tumor biopsies and blood samples from 190 patients starting chemotherapy. The main goal is to see if genetic test results can be returned within 8 weeks, which could make this approach practical for future care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors choose better treatments for pancreatic cancer patients based on their tumor's genetic profile.
What could go wrong
This is an early feasibility study, not a treatment trial. It may not lead to immediate improvements, and genetic testing might not always be useful for all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BC Cancer - Vancouver
RECRUITINGVancouver, British Columbia, V5Z 4E6, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
-
Cross Cancer Institute
WITHDRAWNEdmonton, Alberta, T6G 1Z2, Canada
-
The Ottawa Hospital
ACTIVE_NOT_RECRUITINGOttawa, Ontario, K1H 8L6, Canada
-
Tom Baker Cancer Centre
RECRUITINGCalgary, Alberta, T2N 4N2, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••